Bio-Techne Corporation
TECH
$60.24
$1.773.02%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.62% | -5.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.62% | -5.44% | |||
| Cost of Revenue | -1.07% | -2.91% | |||
| Gross Profit | 4.60% | -6.74% | |||
| SG&A Expenses | 6.51% | 2.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.10% | -0.20% | |||
| Operating Income | 0.45% | -23.55% | |||
| Income Before Tax | 6.73% | -3.58% | |||
| Income Tax Expenses | 21.53% | 512.40% | |||
| Earnings from Continuing Operations | 3.84% | -17.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.84% | -17.22% | |||
| EBIT | 0.45% | -23.55% | |||
| EBITDA | -1.01% | -16.64% | |||
| EPS Basic | 3.92% | -17.55% | |||
| Normalized Basic EPS | -8.47% | -19.39% | |||
| EPS Diluted | 4.76% | -18.29% | |||
| Normalized Diluted EPS | -8.26% | -19.30% | |||
| Average Basic Shares Outstanding | -0.06% | 0.42% | |||
| Average Diluted Shares Outstanding | -0.30% | 0.29% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.03% | 0.21% | |||
